CARDIOTOXICITY
Clinical trials for CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise may reverse heart damage in childhood cancer survivors
Disease control CompletedThis study looked at whether aerobic exercise can help repair heart damage caused by a type of chemotherapy called anthracycline, which is often used to treat childhood cancer. The study included 47 long-term childhood cancer survivors over age 9. Researchers measured changes in …
Matched conditions: CARDIOTOXICITY
Sponsor: Connecticut Children's Medical Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Heart shield: common diabetes drug may protect cancer patients from Chemo-Induced heart damage
Disease control CompletedThis study tested whether dapagliflozin, a drug used for diabetes and heart failure, can prevent heart damage caused by anthracycline chemotherapy. 90 cancer patients took either dapagliflozin or a placebo daily for four months alongside their chemo. Researchers measured heart fu…
Matched conditions: CARDIOTOXICITY
Phase: PHASE2 • Sponsor: Hawler Medical University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Heart shield for chemo: new study tests carvedilol in breast cancer patients
Disease control CompletedThis early-phase study tested whether giving the heart medication carvedilol to breast cancer patients at high risk for heart problems could safely protect their hearts during chemotherapy with doxorubicin and/or trastuzumab. 68 women with stage I-III breast cancer participated. …
Matched conditions: CARDIOTOXICITY
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
CAR T-Cell Therapy's hidden heart risk revealed
Knowledge-focused CompletedThis study watched 44 adults with leukemia or lymphoma who were getting CAR T-cell therapy. Researchers checked their heart health before and after treatment using heart scans and blood tests. The goal was to see how often heart problems happen and who might be at higher risk.
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 00:52 UTC
-
Which breast cancer radiation is safer for the heart? new study investigates
Knowledge-focused CompletedThis study looked at 172 breast cancer patients to see how proton or photon radiation affects the heart. Researchers measured heart function and blood markers before, during, and up to one year after treatment. The goal was to understand which type of radiation might cause less h…
Matched conditions: CARDIOTOXICITY
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 00:51 UTC
-
Heart risk from breast cancer therapy: can MRI predict damage?
Knowledge-focused CompletedThis study looked at 150 breast cancer patients to see if MRI scans could detect early signs of heart damage caused by radiation and certain chemotherapy drugs. The goal was to predict which patients might develop heart problems within a year after treatment. Researchers measured…
Matched conditions: CARDIOTOXICITY
Sponsor: Oncology Institute of Southern Switzerland • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC
-
Exercise program tested to protect hearts of young cancer survivors
Knowledge-focused CompletedThis pilot study tested whether a structured exercise program is practical and safe for young cancer survivors (ages 18-45) who are at risk for heart problems due to past treatments. The study enrolled 30 participants and focused on measuring recruitment, safety, and how well par…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC
-
Lung cancer drug heart risks revealed in new study
Knowledge-focused CompletedThis study looked at how often heart problems happen in people with advanced lung cancer who take a type of targeted drug called EGFR-TKIs. Researchers followed 100 patients to see if their heart function changed. The goal was to better understand these side effects, not to test …
Matched conditions: CARDIOTOXICITY
Sponsor: Taichung Veterans General Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC